Evidence map›Paper›PMID 41714979›Full record

ArticleBMC nephrology2026

Real-world use of HIF-PH inhibitors in the Japan dialysis and practice patterns study (J-DOPPS, 2019-2022).

Masahiro Eriguchi, Kazuhiko Tsuruya, Hisashi Noma, Yoshihiro Onishi, Masami Inuzuka, Kenji Harada, Masaomi Nangaku

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Masahiro EriguchiDepartment of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan. meriguci@gmail.com.
Kazuhiko TsuruyaDepartment of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Hisashi NomaDepartment of Data Science, The Institute of Statistical Mathematics, Tachikawa, Japan.
Yoshihiro OnishiInstitute for Health Outcomes and Process Evaluation Research (iHope International), Kyoto, Japan.
Masami InuzukaMedical Affairs Department, Kyowa Kirin Co.,Ltd, Tokyo, Japan.
Kenji HaradaMedical Affairs Department, Kyowa Kirin Co.,Ltd, Tokyo, Japan.
Masaomi NangakuDivision of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia in chronic kidney diseaseC-reactive protein (CRP)Erythropoiesis-stimulating agents (ESAs)Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs)Maintenance hemodialysis patients

Identifiers

PMID41714979
PMCPMC13097766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.